Nancy Devlin
Publications and Insights
- Publication: Anchoring Latent Scale Values for the EQ-5D-Y at 0 = Dead
- Publication: Valuing EQ-5D-Y Health States Using a Discrete Choice Experiment: Do Adult and Adolescent Preferences Differ?
- Publication: Can We Really Compare and Aggregate PRO Data Between People and Settings? Implications for Multi-Country Clinical Trials and HTA
- Publication: Exploring Variations in the Opportunity Cost Cost-effectiveness Threshold by Clinical Area: Results from a Feasibility Study in England
- Publication: Public Preferences for Health Gains and Cures: A Discrete Choice Experiment
- Publication: Quality of Life in Long-term Cancer Survivors: Implications for Future Health Technology Assessments in Oncology
- Publication: A New Valuation Method: Directly Eliciting Personal Utility Functions
- Publication: Age and Utilities: Issues for HTA
- Publication: Comparing the UK EQ-5D-3L and the English EQ-5D-5L Value Sets
- Publication: What is the Normative Basis for Selecting the Measure of ‘Average’ Preferences for Use in Social Choices?
- Publication: An Analysis of NICE Technology Appraisal Decisions ‘Recommended in Line with Clinical Practice’
- Publication: Applying a Multi-criteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy. The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL)
- Publication: An Investigation of the Feasibility and Cultural Appropriateness of Stated Preference Methods to Generate EQ-5D-5L Values in the United Arab Emirates
- Publication: Do Respondents Completing Abstract, Hypothetical Priority-setting Exercises Agree With the Policy Implications of Their Choices?
- Publication: What Determines the Shape of an EQ-5D Index Distribution?
- Publication: Time Trends in NICE HTA Decisions
- Publication: The Evolution of HTA in Emerging Markets Health Care Systems: Analysis to Support a Policy Response
- Publication: A Comparison of Alternative Variants of the Lead and Lag Time TTO
- Publication: How Much Should We Spend on the NHS?
- Publication: Cost-Effectiveness Thresholds: Economic and ethical issues